Riskpilot← Back to searchSign inGet full accessNordiskt Hälsovård AB
ABActiveOrg 5569346249Stålgatan 3General medical practice activities · NACE 8621Est. 20130 employees
Revenue 2024
SEK 298K
-74% vs 2023
EBITDA margin
-73.8%
-226% vs 2023
Equity ratio
71.2%
Financial strength
Net profit 2024
SEK -228K
-259% vs 2023
| Revenue | SEK 298K | -74% |
| EBITDA | SEK -220K | -226% |
| Net profit | SEK -228K | -259% |
| Total assets | SEK 73K | -78% |
| Equity | SEK 52K | -75% |
| Employees | 0 | — |
Legal name
Nordiskt Hälsovård AB
Org number
5569346249
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 juni 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Vitikainen, Harri Tapio Vitikainen, Marja-Liisa
Company purpose
Hälsovård, Mineraler och Läkartjänster. Utbildning och uthyrning av personal inom nämnda områden.
Address
Stålgatan 3
Email
harri_vitikainen@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 768 | 653 | 707 | 1 134 | 298 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 266 | 155 | −54 | 175 | −220 |
| Depreciation & amort. | −156 | −0 | −0 | −8 | −8 |
| EBIT | 110 | 155 | −54 | 167 | −228 |
| Net financials | −13 | −3 | −6 | −2 | — |
| Profit before tax | 96 | 151 | −59 | 165 | −228 |
| Tax | −21 | −31 | −0 | −22 | −0 |
| Net profit | 75 | 120 | −59 | 143 | −228 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 578 | 573 | 421 | 331 | 73 |
| Equity | 476 | 421 | 162 | 205 | 52 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 102 | 152 | 259 | 126 | 21 |
| Total debt | 102 | 152 | 259 | 126 | 21 |
EBITDA margin
-73.8%
This company
15.8%
Market median
-567% vs market
20202024
Equity ratio
71.2%
This company
38.2%
Market median
+86% vs market
20202024
Return on equity
-438.5%
This company
18.4%
Market median
-2483% vs market
20202024
Net profit margin
-76.5%
This company
8.1%
Market median
-1044% vs market
20202024
Asset turnover
4.08×
This company
1.12×
Market median
+264% vs market
20202024
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HT Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nordiskt Hälsovård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Harri Tapio Vitikainen | Chief Executive Officer | 0 companies |
| Margit Irja Hannele Vitikainen | Deputy Board Member | 0 companies |
| Marja-Liisa Vitikainen | Deputy Board Member | 0 companies |